A Multicentric open label non-interventional post marketing Surveillance study to evaluate safety and tolerability of BE's inactivated vero cell derived Japanese Encephalitis vaccine in ≥ 1 to ≤ 3 year old healthy children in a two dose schedule. - None

Trial Profile

A Multicentric open label non-interventional post marketing Surveillance study to evaluate safety and tolerability of BE's inactivated vero cell derived Japanese Encephalitis vaccine in ≥ 1 to ≤ 3 year old healthy children in a two dose schedule. - None

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs IC 51 (Primary)
  • Indications Japanese encephalitis
  • Focus Adverse reactions
  • Sponsors Biological E Limited
  • Most Recent Events

    • 01 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top